REGENXBIO Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $349.6M | $1.11B | $345.2M |
| FY2022 | $317.1M | $833.3M | $97.0M |
| FY2023 | $262.2M | $574.0M | $34.5M |
| FY2024 | $206.3M | $466.0M | $57.5M |
| FY2025 | $350.3M | $453.0M | $34.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $349.6M | $1.11B | $345.2M |
| FY2022 | $317.1M | $833.3M | $97.0M |
| FY2023 | $262.2M | $574.0M | $34.5M |
| FY2024 | $206.3M | $466.0M | $57.5M |
| FY2025 | $350.3M | $453.0M | $34.5M |